CDH2 and melanoma: Moreover, we also revealed a significant correlation between enhanced immunoreactivity of ADAM-10 and augmented expression of N-cadherin and SPARC in primary tumor cells and melanoma cells in nodal metastases which may be associated with the potential role of ADAM-10 in the process of EMT [10, 11].